JP2025504430A5 - - Google Patents
Info
- Publication number
- JP2025504430A5 JP2025504430A5 JP2024542129A JP2024542129A JP2025504430A5 JP 2025504430 A5 JP2025504430 A5 JP 2025504430A5 JP 2024542129 A JP2024542129 A JP 2024542129A JP 2024542129 A JP2024542129 A JP 2024542129A JP 2025504430 A5 JP2025504430 A5 JP 2025504430A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- formula
- alkyl group
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22305043 | 2022-01-17 | ||
| EP22305043.6 | 2022-01-17 | ||
| PCT/EP2023/050891 WO2023135305A1 (en) | 2022-01-17 | 2023-01-16 | Lipidic compounds, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504430A JP2025504430A (ja) | 2025-02-12 |
| JP2025504430A5 true JP2025504430A5 (https=) | 2025-12-16 |
Family
ID=80445819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542129A Pending JP2025504430A (ja) | 2022-01-17 | 2023-01-16 | 脂質化合物及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250114305A1 (https=) |
| EP (1) | EP4466248A1 (https=) |
| JP (1) | JP2025504430A (https=) |
| KR (1) | KR20240136397A (https=) |
| CN (1) | CN118829624A (https=) |
| AU (1) | AU2023206629A1 (https=) |
| CA (1) | CA3248846A1 (https=) |
| WO (1) | WO2023135305A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025089792A1 (ko) * | 2023-10-24 | 2025-05-01 | 주식회사 삼양홀딩스 | 약물전달용 나노입자의 조성물 |
| WO2025141521A1 (en) | 2023-12-29 | 2025-07-03 | Sanofi | Lipids having dendritic moieties |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5573726A (en) * | 1993-09-22 | 1996-11-12 | Alcon Laboratories, Inc. | Use of amidoamines in ophthalmic compositions |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| AU2013370592B2 (en) * | 2012-12-28 | 2017-08-31 | Nalco Company | Beta-amino ester gas hydrate inhibitors |
| JPWO2014112280A1 (ja) * | 2013-01-17 | 2017-01-19 | 学校法人日本大学 | 油性組成物及び増粘又はゲル形成剤 |
| KR102354389B1 (ko) | 2013-08-21 | 2022-01-20 | 큐어백 아게 | Rna―암호화된 단백질의 발현을 증가시키는 방법 |
| US10426737B2 (en) * | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| CN110402145A (zh) * | 2016-10-26 | 2019-11-01 | 莫得纳特斯公司 | 用于增强免疫应答的信使核糖核酸及其使用方法 |
| US20190314291A1 (en) * | 2018-01-30 | 2019-10-17 | Modernatx, Inc. | Compositions and methods for delivery of agents to immune cells |
| KR20210149686A (ko) | 2018-12-27 | 2021-12-09 | 라이프에디트 테라퓨틱스, 인크. | 유전자 편집에 유용한 폴리펩티드 및 사용 방법 |
| CN114127044A (zh) * | 2019-04-25 | 2022-03-01 | 英特利亚治疗股份有限公司 | 可电离的胺类脂质和脂质纳米颗粒 |
| IL294318A (en) * | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
-
2023
- 2023-01-16 CA CA3248846A patent/CA3248846A1/en active Pending
- 2023-01-16 AU AU2023206629A patent/AU2023206629A1/en active Pending
- 2023-01-16 JP JP2024542129A patent/JP2025504430A/ja active Pending
- 2023-01-16 US US18/729,020 patent/US20250114305A1/en active Pending
- 2023-01-16 EP EP23700880.0A patent/EP4466248A1/en active Pending
- 2023-01-16 WO PCT/EP2023/050891 patent/WO2023135305A1/en not_active Ceased
- 2023-01-16 CN CN202380024454.XA patent/CN118829624A/zh active Pending
- 2023-01-16 KR KR1020247027282A patent/KR20240136397A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025504430A5 (https=) | ||
| JP2020510072A5 (https=) | ||
| TW202248190A (zh) | 脂質化合物、其組合物、其藥物組合物、製備脂質奈米顆粒的方法及其用途 | |
| ES2543841T3 (es) | El uso de los esteroides pregnano y androstano en la fabricación de una composición farmacéutica para el tratamiento de trastornos del SNC | |
| JP2022539089A5 (https=) | ||
| JP2002503695A (ja) | エストロゲン及び抗エストロゲンから成る組合せ製剤 | |
| JP2019500430A5 (https=) | ||
| JP2022502451A5 (https=) | ||
| JP2018533573A5 (https=) | ||
| HRP20220156T1 (hr) | Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava | |
| CA2205022A1 (fr) | Adjuvant pour composition vaccinale | |
| JP2008512446A (ja) | グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物 | |
| JP2010510327A (ja) | エンドキシフェンの方法および組成物 | |
| WO2023179497A1 (zh) | 一种脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂 | |
| WO2003039480A2 (en) | Method of treating disorder related to high cholesterol concentration | |
| JP2026503201A5 (https=) | ||
| JP2022523704A5 (https=) | ||
| US7078396B2 (en) | Method of treating disorder related to high cholesterol concentration | |
| JP4324343B2 (ja) | トリヨードフェニル基及びステロイド残基を有する化合物 | |
| JP2024543272A5 (https=) | ||
| WO2025113662A1 (zh) | 一种用于递送核酸的脂质纳米颗粒及其制备方法和用途 | |
| EP4683905A1 (en) | Ionizable anionic lipids | |
| JP4046691B2 (ja) | トリシクロ［５．２．１．０▲２▼▲．▼▲６▼］−デク−９−イルキサントゲネートの純粋な立体異性体の製造方法およびそれからなる医薬品 | |
| CN117417264B (zh) | 氨基脂质化合物、其制备方法和应用 | |
| GB2079285A (en) | Diphosphonate derivatives and pharmaceutical compositions containing them |